Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Liquidia Technologies Inc (LQDA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/23/2021 |
GN
| Liquidia Corporation Reports Full-Year 2020 Financial Results and Provides Corporate Update |
| 03/09/2021 |
GN
| Liquidia Corporation to Host 2020 Financial Results Conference Call on March 23, 2021 |
| 03/02/2021 |
GN
| Liquidia Corporation Secures $20.5 Million Debt Facility with Silicon Valley Bank |
| 12/20/2020 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA |
| 12/07/2020 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA |
| 11/30/2020 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Liquidia Corporation – LQDA |
| 11/30/2020 |
GN
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA |
| 11/30/2020 |
GN
| Liquidia Corporation Appoints Michael Kaseta Chief Financial Officer |
| 11/18/2020 |
GN
| Liquidia Closes Acquisition of RareGen |
| 11/16/2020 |
GN
| Liquidia Announces Results of Special Meeting of Stockholders |
| 11/09/2020 |
GN
| Liquidia Reports Third Quarter 2020 Financial Results and Provides Corporate Update |
| 11/02/2020 |
GN
| Liquidia Reschedules Special Meeting of Stockholders and Reaffirms Recommendation to Approve Proposed Acquisition of RareGen, LLC |
| 10/30/2020 |
GN
| UPDATE – Liquidia to Report Third Quarter 2020 Financial Results and Provide Corporate Update on November 6, 2020 |
| 10/30/2020 |
GN
| Liquidia to Report Third Quarter 2020 Financial Results and Provide Corporate Update on November 6, 2020 |
| 10/19/2020 |
GN
| Liquidia Announces Postponement of Special Meeting of Stockholders |
| 10/14/2020 |
GN
| Liquidia Provides Update on U.S. Patent Trial and Appeal Board Decision on Inter Partes Review of Two United Therapeutics' Tyvaso® Patents |
| 10/05/2020 |
GN
| Liquidia Names Gerald M. O'Brien, MD, as Vice President, Pulmonary Clinical Development |
| 09/17/2020 |
GN
| Liquidia Announces Special Meeting Date to Approve Proposed Acquisition of RareGen, LLC |
| 08/28/2020 |
GN
| Liquidia Announces Notice of Allowance for U.S. Patent Application Covering Methods of Treating Pulmonary Hypertension with Dry Powder Treprostinil |
| 08/20/2020 |
GN
| Liquidia Announces Chief Financial Officer Transition |
| 08/10/2020 |
GN
| Liquidia Reports Second Quarter 2020 Financial Results and Provides Corporate Update |
| 08/05/2020 |
GN
| Liquidia to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference |
| 08/05/2020 |
GN
| Liquidia Releases Exploratory Endpoint Data from INSPIRE Study at the American Thoracic Society (ATS) Annual Meeting |
| 08/03/2020 |
GN
| Liquidia to Report Second Quarter 2020 Financial Results and Provide Corporate Update on August 10, 2020 |
| 07/24/2020 |
GN
| Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of New Tyvaso Patent |
| 07/02/2020 |
GN
| Liquidia Announces Closing of Public Offering of Common Stock |
| 06/29/2020 |
GN
| Liquidia to Host Conference Call to Provide Update on Recent Announcements |
| 06/29/2020 |
GN
| Liquidia Announces Pricing of Public Offering of Common Stock |
| 06/29/2020 |
GN
| Liquidia Announces Proposed Offering of Common Stock |
| 06/29/2020 |
GN
| Liquidia to Acquire RareGen, LLC, and Expand Presence in PAH |
|
|